List of articles in "Drug" category - Page 15

Saroglitazar (INN trade name Lipaglyn) is a drug for the treatment of type II diabetes. It is approved for use in India by the Drug Controller General of India.

Arbaclofen placarbil (ar-BAC-loe-fen pla-KAR-bil also known as XP19986) is a prodrug of R-baclofen. Arbaclofen placarbil possesses more favorable pharmacokinetic profile than baclofen with less fluctuations in plasma drug levels. It […]

SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors with an EC50 for CB1 activation of 19nM and 7x selectivity for CB1 over CB2. It […]

AM-1714 is a drug that acts as a reasonably selective agonist of the peripheral cannabinoid receptor CB2 with sub-nanomolar affinity and 490x selectivity over the related CB1 receptor. In animal […]

NESS-040C5 is a potent cannabinoid agonist which was developed for the treatment of glaucoma. It has reasonable selectivity for the CB2 receptor subtype having a CB2 affinity of 0.4nM and […]

PSB-SB-1202 is a coumarin derivative which is an agonist at the cannabinoid receptors CB1 and CB2 with a CB1 Ki of 32nM and a CB2 Ki of 49nM. It is […]

PSB-SB-487 is a coumarin derivative which is an antagonist at the former orphan receptor GPR55. Unlike older GPR55 antagonists such as O-1918 PSB-SB-487 has good selectivity over the related receptor […]

Ipidacrine (Neiromidin) is a novel substance synthesized by the National Research Center for Biologically Active Compounds in the Russian Federation. This compound contains the structure of 4-aminopyridine and is structurally […]

Tenoten or Тенотен is a homeopathic Russian drug proposed to have anxiolytic and antidepressant properties based on antibodies to brain-specific protein S-100B. S100 proteins are small calcium-binding proteins interacting with […]

Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer.In a phase 2 trial reported at the April 2014 […]